Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial ...

Researchers discuss contributors to nasal polyp development in children, as well as the risk of co-occuring conditions and current methods of treatment. Although rarely reported in childhood, nasal ...

Clinical Associate Professor of Medicine, Department of Internal Medicine and Gastroenterology, MCP Hahnemann University, Philadelphia, Pennsylvania; Chief, Division of Internal Medicine, Department ...

Please provide your email address to receive an email when new articles are posted on . Patients had severe chronic rhinosinusitis with nasal polyps. Symptoms persisted prior to the study despite ...

Earlier initiation of average-risk screening at age 45 reflects increasing concern about younger-onset colorectal cancer ...

WALTHAM, Mass.--(BUSINESS WIRE)--Upstream Bio, a clinical-stage biotech company advancing new therapies to treat inflammation, today announced the dosing of the first patients in a Phase 2 clinical ...

While colorectal cancer polyps often have no symptoms—especially in the early stages—there are some warning signs to be on ...

Although nasal polyps are noncancerous, these soft growths in the lining of your sinuses or nasal passages can worsen if your body's inflammation levels rise. That can lead to uncomfortable symptoms ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...